Publisher
Springer Science and Business Media LLC
Reference36 articles.
1. Liyanage T, Ninomiya T, Jha V, Neal B, Patrice HM, Okpechi I et al (2015) Worldwide access to treatment for end-stage kidney disease: a systematic review. Lancet 385(9981):1975–1982
2. Samokhvalova NA, Romanchishen AF, Gerasimchuk RP, Grinev KM, Zemchenkov A (2007) Secondary hyperparathyroidism: incidence, clinical presentations, treatment. Vestn Khir Im I I Grek 166(5):78–81
3. Adler JT, Sippel RS, Chen H (2010) New trends in parathyroid surgery. Curr Probl Surg 47(12):958–1017
4. Tentori F, Wang M, Bieber BA, Karaboyas A, Li Y, Jacobson SH et al (2015) Recent changes in therapeutic approaches and association with outcomes among patients with secondary hyperparathyroidism on chronic hemodialysis: the DOPPS study. Clin J Am Soc Nephrol 10(1):98–109
5. Bureo JC, Arevalo JC, Anton J, Adrados G, Jimenez Morales JL, Robles NR et al (2015) Prevalence of secondary hyperparathyroidism in patients with stage 3 and 4 chronic kidney disease seen in internal medicine. Endocrinol Nutr 62(7):300–305